Filing Details
GOLDENWELL BIOTECH, INC. (OTC:GWLL) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
8k filedOTC:GWLL
GOLDENWELL BIOTECH, INC. (GWLL) Reports Material Event to SEC
GOLDENWELL BIOTECH, INC. (OTC:GWLL) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
At publication ·
What changed
GOLDENWELL BIOTECH, INC. (OTC:GWLL) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- GOLDENWELL BIOTECH, INC. (GWLL) filed a Form 8-K on October 09, 2026, disclosing a material event that shareholders should know about.
- The stock trades at $0.69 per share with a market capitalization of $297.0 million as of the filing date.
- Material events reported on Form 8-K can include leadership changes, acquisitions, asset sales, or changes to financial guidance.
Market Context
GOLDENWELL BIOTECH, INC.'s stock currently trades at $0.69 with a market capitalization of $297.0M. The Consumer Defensive company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for GOLDENWELL BIOTECH, INC.'s stock.
All SEC filings for GOLDENWELL BIOTECH, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GWLL Stock Page
Frequently Asked Questions
Where can I read GWLL's SEC filings?
Browse all filings on our GWLL SEC filings page.
What types of SEC filings does GOLDENWELL BIOTECH, INC. file?
Public companies like GOLDENWELL BIOTECH, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.